The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection

The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease

(2021) Wei-Chung Chiou et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

(2020) Victor M Corman et al.   Eurosurveillance

A new coronavirus associated with human respiratory disease in China

(2020) Fan Wu et al.   NATURE

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

(2020) Camilla Rothe et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Virological assessment of hospitalized patients with COVID-2019

(2020) Roman Wölfel et al.   NATURE

A human monoclonal antibody blocking SARS-CoV-2 infection

(2020) Chunyan Wang et al.   Nature Communications

Initial Step of Virus Entry: Virion Binding to Cell-Surface Glycans

(2020) Melanie Koehler et al.   Annual Review of Virology

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

(2020) Marta Menegazzi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

(2020) W. Joost Wiersinga et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

(2020) Fabian Schmidt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics

(2020) Eskild Petersen et al.   LANCET INFECTIOUS DISEASES

Evaluation of medicinal herbs as a potential therapeutic option against SARS‐CoV ‐2 targeting its main protease

(2020) Saurabh Upadhyay et al.   PHYTOTHERAPY RESEARCH

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

(2020) Xiangyang Chi et al.   SCIENCE

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

(2020) Thomas Mandel Clausen et al.   CELL

Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection

(2020) Chang Li et al.   VIRUS RESEARCH

Current Prevention of COVID-19: Natural Products and Herbal Medicine

(2020) Junqing Huang et al.   Frontiers in Pharmacology

A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine

(2020) Cindy Hörner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex

(2019) Lisa Henss et al.   Viruses-Basel

ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication

(2019) Zi-yu Wang et al.   ACTA PHARMACOLOGICA SINICA

Origin and evolution of pathogenic coronaviruses

(2018) Jie Cui et al.   NATURE REVIEWS MICROBIOLOGY

The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection

(2015) Christopher Weber et al.   ANTIVIRAL RESEARCH

High Secretion of Interferons by Human Plasmacytoid Dendritic Cells upon Recognition of Middle East Respiratory Syndrome Coronavirus

(2015) Vivian A. Scheuplein et al.   JOURNAL OF VIROLOGY

Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication

(2015) L Zhong et al.   Cell Death & Disease

(−)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes

(2014) Hsiu-Chen Huang et al.   ANTIVIRAL RESEARCH

A Small Molecule Inhibits Virion Attachment to Heparan Sulfate- or Sialic Acid-Containing Glycans

(2014) Che C. Colpitts et al.   JOURNAL OF VIROLOGY

Inhibition of influenza virus internalization by (−)-epigallocatechin-3-gallate

(2013) Meehyein Kim et al.   ANTIVIRAL RESEARCH

(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells

(2012) S. Liu et al.   CARCINOGENESIS

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

(2012) Ali M. Zaki et al.   NEW ENGLAND JOURNAL OF MEDICINE

EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1

(2011) Ya-Lin Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications

(2011) Brahma N. Singh et al.   BIOCHEMICAL PHARMACOLOGY

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

(2011) Sandra Ciesek et al.   HEPATOLOGY

(−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry

(2011) Noémie Calland et al.   HEPATOLOGY

Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line

(2011) Wei He   WORLD JOURNAL OF GASTROENTEROLOGY

Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63

(2009) I. Glowacka et al.   JOURNAL OF VIROLOGY